IL17B and breast carcinoma: Recent studies showed that the IL17B/IL17RB cascade promotes antiapoptosis and tumorigenesis in breast cancer [41,42] and facilitates invasion, vasculogenic endothelial cells and the macrophage recruitment of pancreatic cancer cells [43].